<DOC>
	<DOCNO>NCT01028794</DOCNO>
	<brief_summary>The purpose study determine whether autologous bone marrow mononuclear cell transplantation stroke safe and/or effective improve neurological outcome .</brief_summary>
	<brief_title>Autologous Bone Marrow Mononuclear Cell Transplantation Stroke Patients</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Intracranial Embolism</mesh_term>
	<criteria>Patients cerebral embolism . NIHSS score ( equal ) 10 . On day 7 onset stroke , improvement NIHSS le ( equal ) 5 , compare level administration . Bone marrow aspiration do 10 day onset stroke Patient cerebral hemorrhage symptomatic hemorrhagic infarction . Patient expect brain surgery . Patient acute myocardial infarction . Patient coagulation disorder . Number Platelet &lt; 100000/mm3 Serum creatinine level &gt; 2.0mg/dl Patient malignancy . Patient uncontrolled proliferative diabetic retinopathy . Patient suspect infective endocarditis . HBV , HCV , HIV HTLV positive</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>stroke</keyword>
	<keyword>bone marrow</keyword>
	<keyword>mononuclear cell</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>neurogenesis</keyword>
</DOC>